First, as most studies on miRNA in the treatment of chronic inflammation-mediated nervous system diseases focus on NF-κB signaling, MAPK signaling, and NLRP3 inflammasome pathways, more attention should be paid to discover new signaling pathways. This evidence concerns the gene NFKB1 and nervous system disorder.